Genomma Lab Internacional SAB De CV (LABB)

Currency in MXN
20.990
+0.050(+0.24%)
Real-time Data·
Showing Genomma Lab Int historical data. For real-time data please try another search
Day's Range
20.57021.370
52 wk Range
15.03021.370
Key Statistics
Prev. Close
20.88
Open
20.9
Day's Range
20.57-21.37
52 wk Range
15.03-15.75
Volume
1.7M
Average Volume (3m)
4.87M
1-Year Change
37.91%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral

Genomma Lab Internacional SAB De CV Company Profile

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, antacids, anti-ulcers, anti-flu, protection and improvement products, treatments against hemorrhoids, against varicose veins, osteoarthritis, ophthalmic medications, infant nutrition, and others. Genomma Lab Internacional, S.A.B. de C.V. was incorporated in 1996 and is based in Mexico City, Mexico.

Industry
-
Sector
-
Employees
1708
Market
Mexico

Genomma Lab Internacional SAB De CV Earnings Call Summary for Q3/2025

  • Net sales fell 12.8% in Q3 2025, but EBITDA margin held at 23.7%; adjusted net income down 3% to 632 million pesos
  • Free cash flow decreased 35% to 1.6 billion pesos; company maintains strong gross profit margin of 63.4%
  • Genomma Lab targets $5 billion in incremental sales for 2026-2027, aiming to maintain 24% EBITDA margin
  • Significant investments planned in product innovation, particularly in OTC, beverage, and personal care segments
  • Gradual recovery expected in H1 2026; company faces challenges in Mexico market and Argentine currency depreciation
Last Updated: 23/10/2025, 19:28
Read Full Transcript

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.71%
Dividend Yield
4.26%
Industry Median -
Annualised payout
0.80
Paid unevenly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Oct 22, 2025
EPS / Forecast
0.44 / --
Revenue / Forecast
4.44B / --
EPS Revisions
Last 90 days

LABB Income Statement

People Also Watch

185.81
AC
-0.50%
47.700
BBAJIOO
-0.65%
162.570
GMEXICOB
+1.92%
61.230
WALMEX
-1.23%
13.17
VOLARA
-0.53%
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.